The ancient Japanese art of flower arranging was the inspiration for a groundbreaking technique to create tiny “artificial brains” that could be used to develop personalized cancer treatments.
The organoids, clusters of thousands of human brain cells, cannot perform a brain’s basic functions, much less generate thought. But they provide a far more authentic model – the first of its kind – for studying how brain tumours grow, and how they can be stopped.
“This puts the tumour within the context of a brain, instead of a flat plastic dish,” said Christian Naus, a professor in the department of cellular and physiological sciences, who conceived the project with a Japanese company that specializes in bioprinting. He shared details about the technique at November’s annual Society for Neuroscience conference in San Diego. “When cells grow in three dimensions instead of two, adhering only to each other and not to plastic, an entirely different set of genes are activated.”
Naus studies glioblastoma, a particularly aggressive brain cancer that usually takes root deep inside the brain, and easily spreads. The standard care is surgery, followed by radiation and/or chemotherapy, but gliomas almost always return because a few malignant cells manage to leave the tumour and invade surrounding brain tissue. From the time of diagnosis, average survival is one year.
The idea for creating a more authentic model of glioblastoma originated when Naus partnered with a Japanese biotechnology company, Cyfuse, that has developed a particular technique for printing human tissues based on the Japanese art of flower arranging known as ikebana. In ikebana, artists use a heavy plate with brass needles sticking up, upon which the stems of flowers are affixed. Cyfuse’s bioprinting technique uses a much smaller plate covered with microneedles.
Working with Naus and research associate Wun Chey Sin, Kaori Harada of Cyfuse skewered small spheres of human neural stem cells on the microneedles. As the stem cells multiplied and differentiated into brain tissue, they merged and formed larger structures known as organoids, about two millimetres to three millimetres in diameter. Although the organoids lack blood vessels, they are small enough to allow oxygen and nutrients to permeate the tissue.
“The cells make their own environment,” said Naus, Canada Research Chair in Gap Junctions and Neurological Disorders. “We’re not doing anything except printing them, and then they self-assemble.”
The team then implanted cancerous glioma cells inside the organoids. Naus found that the gliomas spread into the surrounding normal cells.
Having shown that the tumour invades the surrounding tissue, Naus envisions that such a technique can be used with a patient’s own cells – both their normal brain cells and their cancerous cells – to grow a personalized organoid with a glioma at its core, and then test a variety of possible drugs or combinations of treatment to see if any of them stop the cancer from growing and invading.
“With this method, we can easily and authentically replicate a model of the patient’s brain, or at least some of the conditions under which a tumour grows in that brain,” said Naus. “Then we could feasibly test hundreds of different chemical combinations on that patient’s cells to identify a drug combination that shows the most promising result, offering a personalized therapy for brain cancer patients.”
Learn more: A traditional Japanese art inspires a futuristic innovation: brain ‘organoids’
[osd_subscribe categories=’organoids’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “ORGANOIDS”‘]
Receive an email update when we add a new ORGANOIDS article.
The Latest on: Organoids
[google_news title=”” keyword=”organoids” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Organoids
- Global Organoids and Spheroids Market: Journey to US$4,567.0 Million Revenue by 2031on May 7, 2024 at 4:45 pm
Global Organoids and Spheroids Market was valued at US$ 771.4 million in 2022 and is projected to attain a valuation of US$ 4,567.0 Million by 2031 at a CAGR of 22.42% During the Forecast Period ...
- Texas Children’s Hospital and Baylor College of Medicine send human brain organoids to the International Space Stationon May 6, 2024 at 4:59 pm
After spending a month in space, the brain organoids returned to the lab yesterday in good condition. The launch offered Dr. Maletic-Savatic and her team at the Duncan NRI an unprecedented opportunity ...
- Human Organoids Market CAGR of 17.5%, Big Money to be Made as Market Size Continues to Surgeon May 5, 2024 at 3:05 pm
Human Organoids Market is valued approximately at USD 723.40 million in 2019 and is anticipated to grow with a healthy growth rate of more than 17.5% over the forecast period 2020-2027. Organoids are ...
- Fetal Organoids Generated From Human Amniotic Fluidon May 2, 2024 at 5:00 pm
Over the last decade, organoids have become an increasingly popular platform for modeling organ function and disease. 3 However, the generation of fetal organoids is complicated by ethical and legal ...
- Scientists develop new organoid model to study thymus functionon April 29, 2024 at 8:08 am
Researchers from the Organoid group have developed a new organoid model that can be used to study the thymus. The organoids are derived from mouse thymus tissue, specifically model thymic epithelial ...
- Human mini-lungs mimic animal response to nanomaterialson April 27, 2024 at 5:05 am
Human mini-lungs grown by University of Manchester scientists can mimic the response of animals when exposed to certain nanomaterials.
- Lab-made miniorgans take scientists a step closer to curing canceron April 25, 2024 at 8:34 am
In the fight to cure cancer, scientists need better models. And they might just get them — human-derived organoids — thanks to light.
- Brain organoids target rare neurological disorderon April 24, 2024 at 8:00 am
Scientists have devised a potential therapy for a rare neurological disease using brain tissue derived from human stem cells, raising hopes that so-called organoid technology can target other ...
- Mini-colon and brain ‘organoids’ shed light on cancer and other diseaseson April 23, 2024 at 5:00 pm
When the researchers injected the cancerous cells into mice, the tumours looked similar to those seen in human colorectal cancer. The organoids accumulated fewer tumours when the researchers ...
via Bing News